Harris Kupperman: Stock Portfolio, Performance and Latest Trades

Praetorian PR

Holdings history from Q1 2023Latest report: Q2 2026, filed August 14, 2026SEC filings (CIK 1949877)
13F portfolio value
$313.8M
14 holdings at Q2 2026

Get an email when Harris Kupperman files a new 13F report

Free, no account needed. Unsubscribe with one click.

Harris Kupperman's portfolio

As of Q2 2026, filed August 14, 2026 · prices as of October 8, 2026

CompanyShare of portfolioAverage buy priceReturnCurrent priceValue nowSharesHeld sinceLast quarterLast change
19.7%$41.99+174%$115.19$63.4M550,000Q2 2024No changeQ4 2024
18.4%$33.34−39.1%$20.31$27.4M1,350,000Q1 2026Added +35%Q2 2026
13.5%$43.41+50.3%$65.25$44M675,000Q1 2023No changeQ1 2026
11.0%$199.66+132%$463.34$62.6M135,000Q3 2025Added +42%Q2 2026
9.71%$34.57——$30.5M500,000Q3 2025No changeQ4 2025
7.90%$16.24+86.0%$30.21$46.1M1,525,000Q4 2024Added +53%Q2 2026
6.22%$168.55+163%$443.80$33.3M75,000Q3 2025Added +25%Q2 2026
5.50%$70.59+15.3%$81.36$16.3M200,000Q4 2025No changeQ1 2026
2.99%$140.40−22.5%$108.76$10.9M100,000Q1 2026Added +122%Q2 2026
2.27%$31.62−26.5%$23.24$3.3M142,500Q1 2026Added +1.1%Q2 2026
1.26%$28.19−79.3%$5.85$2.3M395,000Q3 2025Added +13%Q2 2026
0.62%$12.90−13.8%$11.12$2.2M200,000Q2 2026NewQ2 2026
0.55%$11.48+0.9%$11.58$1.8M154,169Q2 2026NewQ2 2026
0.42%$15.24−9.1%$13.85$1.2M85,000Q2 2026NewQ2 2026

Harris Kupperman's options

As of Q2 2026. Value = shares the options cover.

CompanyTypeValue of shares coveredShares coveredLast quarter
Call · bet on a rise——Sold out
CompanyActionShares changeShares nowValue now
Reduced −42%−400,000550,000$14M
Sold out−459,5000—
Sold out−419,1740—
Added +20%+200,0001,200,000$16.5M
New+665,000665,000$4.4M
Added +5.6%+24,000455,000$19.2M
Added +4.6%+60,0001,375,000$54M
Sold out−80,0000—
Added +6.5%+52,790865,000$6.8M
Sold out−300,0000—
New+1,8501,850$2.7M
Sold out−400,0000—
New+800800$2.1M
New+1,700,0001,700,000$2M
Added +0.6%+5,000835,000$39.2M
Sold out−500,0000—
New+47,51447,514$1.8M
Reduced −23%−59,282202,000$2.1M
New+155,000155,000$1.7M
Added +0.2%+1,980860,000$4.4M
Added +21%+85,000495,000$16.4M
Sold out−1,2500—
Reduced −7.5%−1501,850$3.7M
Inmune Bio Inc.Call45782T905
Added +393%+3,1123,904$1M
Added +25%+100,000500,000$11.9M
New+420,000420,000$650.9K
Reduced −21%−200750$1.7M
New+100,000100,000$124K
Reduced −98%−4,150100$59K
New+10,00010,000$58.1K
Sold out−3000—
New+100100$26.2K
Sold out−14,8950—

Harris Kupperman's portfolio by sector

Share of the stock portfolio at Q2 2026.

31%Financials
SectorShareValueHoldings
Financials31%$96M3
Industrials26%$82.1M3
Energy17%$54M2
Real Estate14%$45.3M3
Other9.7%$30.5M1
Health Care1.3%$4M1
Materials0.6%$1.9M1

Portfolio performance: Harris Kupperman vs. benchmarks

Your result if you had bought each reported portfolio on the day it was made public and held it until the next report, against the S&P 500 and Nasdaq-100.

  • You, copying after each 13F filing – estimated value
  • S&P 500
  • Nasdaq-100
−20%0%+20%+40%+60%+80%+100%+120%+140%Jul2024Jul2025Jul2026Jul+136%Nasdaq-100+103%You, copying+96%S&P 500
May 8, 2023 to Oct 8, 2026, buying on 13F filing dates; prices adjusted for dividends and splits.
Total returnPer year
You, copying after each 13F filing – estimated value+103.5%+23.1%
S&P 500+95.8%+21.7%
Nasdaq-100+135.6%+28.5%

Prices were available for 94% of the portfolio value on average; the rest is left out of the return.

Harris Kupperman's most traded stocks

Quarters with a buy or a sell, all reports since Q1 2023.

CompanyQuarters boughtQuarters soldLast change
146Q1 2026
53Q3 2025
53Q2 2025
24Q1 2025
33Q1 2025
42Q2 2024
41Q1 2026
41Q2 2025
40Q2 2026
31Q2 2026
31Q2 2026
31Q2 2026
40Q2 2026
31Q1 2026
04Q3 2025